VM Chart by TradingView

Business Description

Voyageur Pharmaceuticals Ltd., holder of three barium projects in B.C., including one with a resource estimate, and iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry.

Website https://voyageurpharmaceuticals.ca/

FRC Analyst's Reports

Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Robust PEA / Launching First Suite of Products Next Month Mar. 18, 2022
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company Jan. 7, 2020


InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC – Video Available on Investmentpitch.com Jan. 13, 2022
IIROC Trading Resumption – VM Jan. 11, 2022
IIROC Trading Halt – VM Jan. 11, 2022
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Summit Nanotech to Develop Iodine Extraction Technology and Additions to Scientific Advisory Board – Video Available on Investmentpitch.com Nov. 9, 2021
Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians Oct. 18, 2021

This company was mentioned in the following "Analysts’ Ideas Of The Week":

Investors are also interested in these companies: